5 results on '"Claro da Silva T"'
Search Results
2. Vitamin D3 transactivates the zinc and manganese transporter SLC30A10 via the Vitamin D receptor.
- Author
-
Claro da Silva T, Hiller C, Gai Z, and Kullak-Ublick GA
- Subjects
- Adult, Binding Sites, Caco-2 Cells, Calcium Channels genetics, Calcium Channels metabolism, Cation Transport Proteins agonists, Cation Transport Proteins metabolism, Ceruloplasmin genetics, Ceruloplasmin metabolism, Duodenum metabolism, Female, Gene Ontology, Genes, Reporter, Haptoglobins genetics, Haptoglobins metabolism, Humans, Iron metabolism, Luciferases genetics, Luciferases metabolism, Male, Manganese metabolism, Molecular Sequence Annotation, Prospective Studies, Protein Binding, Receptors, Calcitriol agonists, Receptors, Calcitriol metabolism, Retinoid X Receptors genetics, Retinoid X Receptors metabolism, TRPV Cation Channels genetics, TRPV Cation Channels metabolism, Zinc metabolism, Zinc Transporter 8, Calcitriol administration & dosage, Cation Transport Proteins genetics, Duodenum drug effects, Receptors, Calcitriol genetics, Transcriptional Activation drug effects
- Abstract
Vitamin D3 regulates genes critical for human health and its deficiency is associated with an increased risk for osteoporosis, cancer, diabetes, multiple sclerosis, hypertension, inflammatory and immunological diseases. To study the impact of vitamin D3 on genes relevant for the transport and metabolism of nutrients and drugs, we employed next-generation sequencing (NGS) and analyzed global gene expression of the human-derived Caco-2 cell line treated with 500nM vitamin D3. Genes involved in neuropeptide signaling, inflammation, cell adhesion and morphogenesis were differentially expressed. Notably, genes implicated in zinc, manganese and iron homeostasis were largely increased by vitamin D3 treatment. An ∼10-fold increase in ceruloplasmin and ∼4-fold increase in haptoglobin gene expression suggested a possible association between vitamin D and iron homeostasis. SLC30A10, the gene encoding the zinc and manganese transporter ZnT10, was the chiefly affected transporter, with ∼15-fold increase in expression. SLC30A10 is critical for zinc and manganese homeostasis and mutations in this gene, resulting in impaired ZnT10 function or expression, cause manganese intoxication, with Parkinson-like symptoms. Our NGS results were validated by real-time PCR in Caco-2 cells, as well as in duodenal biopsies taken from healthy human subjects treated with 0.5μg vitamin D3 daily for 10 days. In addition to increasing gene expression of SLC30A10 and the positive control TRPV6, vitamin D3 also increased ZnT10 protein expression, as indicated by Western blot and cytofluorescence. In silico identification of potential vitamin D responsive elements (VDREs) in the 5'-flanking region of the SLC30A10 promoter and dual-luciferase reporter assay showed enhanced promoter activity in the presence of vitamin D receptor (VDR) and retinoid X receptor (RXR) constructs, as well as vitamin D3, but not when one of these factors was absent. Electrophoretic mobility shift assay (EMSA) and competition EMSA revealed binding of select sequences, namely, nt -1623/-1588 and nt -1758/-1723 relative to the transcription start site, to VDR-containing nuclear extracts. In conclusion, we have shown that vitamin D3 transactivates the SLC30A10 gene in a VDR-dependent manner, resulting in increased ZnT10 protein expression. Because SLC30A10 is highly expressed in the small intestine, it is possible that the control of zinc and manganese systemic levels is regulated by vitamin D3 in the intestine. Zinc, manganese and vitamin D are important for bone metabolism and brain health. Future examination of a possible role for supplementation or chelation of zinc and manganese, alongside vitamin D3 administration, will further our understanding of its potential benefit in the treatment of specific illnesses, such as osteoporosis and Parkinson's disease., (Copyright © 2016 The Author(s). Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
3. No major effects of vitamin D3 (1,25 dihydroxyvitamin D3) on absorption and pharmacokinetics of folic acid and fexofenadine in healthy volunteers.
- Author
-
Kullak-Ublick GA, Gubler C, Spanaus K, Ismair MG, Claro da Silva T, and Jetter A
- Subjects
- ATP Binding Cassette Transporter, Subfamily B, Member 1 genetics, Administration, Oral, Adult, Duodenum drug effects, Duodenum metabolism, Female, Folic Acid blood, Healthy Volunteers, Humans, Male, Multidrug Resistance-Associated Proteins genetics, Organic Anion Transporters genetics, Proton-Coupled Folate Transporter genetics, RNA, Messenger metabolism, Terfenadine blood, Terfenadine pharmacokinetics, Vitamin D pharmacology, Young Adult, Folic Acid pharmacokinetics, Intestinal Absorption drug effects, Terfenadine analogs & derivatives, Vitamin D analogs & derivatives
- Abstract
Purpose: In Caco-2 cells, folate uptake via the proton-coupled folate transporter (PCFT) increases significantly by a 3-day treatment with 1,25-dihydroxyvitamin D3 (1,25(OH)2D3). Additionally, mRNA content and protein expression of the transporter OATP1A2 were increased up to ninefold with 1,25(OH)2D3. We investigated whether these in vitro findings can be confirmed in humans in vivo., Methods: Ten healthy volunteers (six women) received 5 mg folic acid orally once before and once together with the last intake of a 10-day course of 0.5 μg 1,25(OH)2D3 orally. One hundred twenty milligrams fexofenadine, an OATP1A2 substrate, was taken in 1 day before the first folic acid intake, and again on the ninth day of 1,25(OH)2D3 intake. Duodenal biopsies were taken for transporter mRNA assessments once before and once on the ninth or tenth day of the vitamin D3 course. Serum folic acid and fexofenadine concentrations were quantified with a chemiluminescence immunoassay and LC-MS/MS, respectively. Pharmacokinetics were compared between periods with standard bioequivalence approaches., Results: While geometric mean folic acid AUC0-2h, which mainly reflects absorption, was 0.403 and 0.414 mg/L·h before and after the vitamin D3 course (geometric mean ratio (GMR), 1.027; 90 % confidence interval (90 % CI), 0.788-1.340), the geometric mean fexofenadine AUC0-2h was 1.932 and 2.761 mg/L·h, respectively (GMR, 1.429; 90 % CI, 0.890-2.294). PCFT- and OATP1A2-mRNA expressions in duodenal biopsies were essentially unchanged., Conclusions: No significant changes in folic acid and fexofenadine absorption were observed after a 10-day course of 1,25(OH)2D3 in humans in vivo. This study underlines the importance of confirming in vitro findings in vivo in humans.
- Published
- 2016
- Full Text
- View/download PDF
4. The solute carrier family 10 (SLC10): beyond bile acid transport.
- Author
-
Claro da Silva T, Polli JE, and Swaan PW
- Subjects
- Genetic Variation, Gonadal Steroid Hormones metabolism, Humans, Models, Biological, Organic Anion Transporters, Sodium-Dependent metabolism, Symporters metabolism, Bile Acids and Salts metabolism, Models, Molecular, Multigene Family genetics, Organic Anion Transporters, Sodium-Dependent genetics, Organic Anion Transporters, Sodium-Dependent physiology, Protein Conformation, Symporters genetics, Symporters physiology
- Abstract
The solute carrier (SLC) family 10 (SLC10) comprises influx transporters of bile acids, steroidal hormones, various drugs, and several other substrates. Because the seminal transporters of this family, namely, sodium/taurocholate cotransporting polypeptide (NTCP; SLC10A1) and the apical sodium-dependent bile acid transporter (ASBT; SLC10A2), were primarily bile acid transporters, the term "sodium bile salt cotransporting family" was used for the SLC10 family. However, this notion became obsolete with the finding of other SLC10 members that do not transport bile acids. For example, the sodium-dependent organic anion transporter (SOAT; SLC10A6) transports primarily sulfated steroids. Moreover, NTCP was shown to also transport steroids and xenobiotics, including HMG-CoA inhibitors (statins). The SLC10 family contains four additional members, namely, P3 (SLC10A3; SLC10A3), P4 (SLC10A4; SLC10A4), P5 (SLC10A5; SLC10A5) and SLC10A7 (SLC10A7), several of which were unknown or considered hypothetical until approximately a decade ago. While their substrate specificity remains undetermined, great progress has been made towards their characterization in recent years. Explicitly, SLC10A4 may participate in vesicular storage or exocytosis of neurotransmitters or mastocyte mediators, whereas SLC10A5 and SLC10A7 may be involved in solute transport and SLC10A3 may have a role as a housekeeping protein. Finally, the newly found role of bile acids in glucose and energy homeostasis, via the TGR5 receptor, sheds new light on the clinical relevance of ASBT and NTCP. The present mini-review provides a brief summary of recent progress on members of the SLC10 family., (Copyright © 2012 Elsevier Ltd. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
5. The cytosolic half of helix III forms the substrate exit route during permeation events of the sodium/bile acid cotransporter ASBT.
- Author
-
Hussainzada N, Claro Da Silva T, and Swaan PW
- Subjects
- Alkylation genetics, Amino Acid Sequence, Animals, Bile Acids and Salts metabolism, Cysteine genetics, Cytosol metabolism, Humans, Membrane Glycoproteins genetics, Membrane Glycoproteins metabolism, Molecular Sequence Data, Mutagenesis, Site-Directed, Organic Anion Transporters, Sodium-Dependent genetics, Organic Anion Transporters, Sodium-Dependent metabolism, Protein Structure, Secondary genetics, Protein Transport genetics, Sodium metabolism, Substrate Specificity genetics, Symporters genetics, Symporters metabolism, Bile Acids and Salts chemistry, Cytosol chemistry, Membrane Glycoproteins chemistry, Organic Anion Transporters, Sodium-Dependent chemistry, Signal Transduction genetics, Sodium chemistry, Symporters chemistry
- Abstract
Site-directed alkylation of consecutively introduced cysteines was employed to probe the solvent-accessible profile of highly conserved transmembrane helix 3 (TM3), spanning residues V127-T149 of the apical sodium-dependent bile acid transporter (ASBT), a key membrane protein involved in cholesterol homeostasis. Sequence alignment of SLC10 family members has previously identified a signature motif (ALGMMPL) localized to TM3 of ASBT with as yet undetermined function. Cysteine mutagenesis of this motif resulted in severe decreases in uptake activity only for mutants M141C and P142C. Additional conservative and nonconservative replacement of P142 suggests its structural and functional importance during the ASBT transport cycle. Significant decreases in transport activity were also observed for three cysteine mutants clustered along the exofacial half of the helix (M129C, T130C, S133C) and five mutants consecutively lining the cytosolic half of TM3 (L145C-T149C). Measurable surface expression was detected for all TM3 mutants. Using physicochemically different alkylating reagents, sites predominantly lining the cytosolic half of the TM3 helix were found to be solvent accessible (i.e., S128C, L143C-T149C). Analysis of substrate kinetics for select TM3 mutants demonstrates significant loss of taurocholic acid affinity for mutants S128C and L145C-T149C. Overall, we conclude (i) the functional and structural importance of P142 during the transport cycle and (ii) the presence of a large hydrophilic cleft region lining the cytosolic half of TM3 that may form portions of the substrate exit route during permeation. Our studies provide unique insight into molecular mechanisms guiding the ASBT transport cycle with respect to substrate binding and translocation events.
- Published
- 2009
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.